From the editor On the web...
Keep up with the latest developments across the industry by visiting
www.worldpharmaceuticals.net
World Pharmaceutical Frontiers 2025 Vol. 1
Editorial Editor Phoebe Galbraith
phoebe.galbraith@
btmi.com
Sub-editor Pete Barden Production manager Dave Stanford Group art director Henrik Williams Designer Martin Faulkner
Commercial Sales manager Nathan Park
nathan.park@
btmi.com
Client services executive Derek Deschamps
World Pharmaceutical Frontiers is published by Business Trade Media International. Registered in England No. 06212740.
www.worldpharmaceuticals.net
ISSN 1742-3791 © 2025
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of the information in this publication, the publisher accepts no responsibility for errors/omissions.
The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.
Subscription records are maintained at Business Trade Media International.
SUBSCRIPTIONS Single issue price: UK £44 EU €68 US $89 RoW $89
One year: Two year:
UK £67 EU €104 US $135 RoW $136 UK £105 EU €163 US $215 RoW $216
Email:
cs@btmi.com
Standard House,12-13 Essex Street, London, WC2R 3AA Tel: +44 20 7936 6400 Printed by Stephens & George Print Group
elcome to the latest edition of World Pharmaceutical Frontiers, where we delve into the transformative innovations shaping the pharmaceutical industry. From groundbreaking advancements in drug delivery to cutting-edge solutions enhancing supply chain transparency, this issue highlights the forces driving progress in global health. As we look closer at innovative excipients – a critical but often underappreciated component of pharmaceutical formulations – these advanced carriers, including lipids and polymers, are improving the bioavailability, stability, and shelf life of medications. By enhancing solubility and absorption, they’re enabling more effective and patient-friendly treatments. On page 46, Abi Millar explores the difference novel excipients are making in drug development. As the pharmaceutical industry continues its push towards innovation, ensuring a secure and transparent supply chain remains essential. On page 40, we examine the role of digital twins and blockchain technology in revolutionising the global pharmaceutical supply chain. These cutting-edge tools are not only enhancing transparency but ensuring compliance and security at every step. Finally, we turn to the rapidly evolving field of AI-driven drug delivery systems. AI is a game changer in healthcare, and its applications in drug delivery design are no exception. By optimising permeability, stability, and effectiveness, AI and machine learning models are unlocking new possibilities for personalised and efficient treatments. On page 16, Monica Karpinski delves into the implications of AI’s growing role in creating next-generation drug carriers. The pharmaceutical industry’s potential to transform lives is greater than ever. As we explore the trends and technologies shaping the future of healthcare, I hope you enjoy this issue as we uncover the innovations driving better outcomes, greater transparency, and more patient-centric solutions across the pharmaceutical industry.
Future frontiers W
Phoebe Galbraith, editor
World Pharmaceutical Frontiers /
www.worldpharmaceuticals.net
3
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58
